Australia’s drug regulator issues mental health warning for weight-loss drugs including Ozempic

December 1, 2025 2

TGA issues a separate warning for Mounjaro about risk of reduced effectiveness of contraception

The medicines regulator has added two new safety warnings about mental health and contraception for people taking high-profile diabetes and weight loss drugs.

The Therapeutic Goods Administration (TGA) says that because suicidal behaviour and ideation have been reported with these relatively new GLP-1 receptor agonists, doctors should “monitor patients for the emergence or worsening of depression, suicidal thoughts or behaviours, and/or any unusual changes in mood or behaviour”.

Source: www.theguardian.com

Read full article

Written by: truelightfm

Rate it